About COVID-RED

COVID-RED is a project that is part of the EU Innovative Medicines Initivative and will evaluate the use and performance of a CE-marked device (wearable), which uses sensors to measure breathing rate, pulse rate, skin temperature, and heart rate variability for the purpose of early detection and monitoring of COVID-19 in general and high-risk populations. At the same time, a mobile application will be used to track participant-reported symptoms.
READ MORE >>

NEWS

LEES MEER
Publication in BMJ Open: Investigation of the use of a sensor bracelet for the presymptomatic detection of changes in physiological parameters related to COVID-19: an interim analysis of a prospective cohort study (COVI-GAPP)
Jun
28
2022
Lees meer >
LEES MEER
Publication in Lancet Digital Health: The performance of wearable sensors in the detection of SARS-CoV-2 infection: a systematic review
Apr
27
2022
Lees meer >

Twitter

Onlangs is er een nieuwe wetenschappelijke #publicatie voortgekomen uit het #COVIDRED onderzoek in @LancetDigitalH: "The performance of wearable sensors in the detection of SARS-CoV-2 infection: a systematic review" https://www.covid-red.eu/news-details/?news_id=1204

We are pleased to let you know that new scientific research from the COVID-RED team has been published in @LancetDigitalH "The performance of wearable sensors in the detection of SARS-CoV-2 infection: a systematic review" Read it here: https://www.sciencedirect.com/science/article/pii/S258975002200019X #science #COVID19

Instagram

6 months ago
6 months ago
7 months ago

COVID-RED

Your support in the fight against COVID-19

The COVID-RED consortium

The COVID-RED consortium brings together nine organisations from four countries with the aim to deliver a large body of information on COVID-19 monitoring that can be used to develop additional diagnostics and therapeutics in addition to validating remote vital signs and self-reported symptoms monitoring systems.

OUR CONSORTIUM
»

The COVID-RED project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101005177. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA.